Flexion Therapeutics Inc (NASDAQ: FLXN) Q4 2020 Earnings Call dated Mar. 10, 2021. Corporate Participants: Scott Young -- Vice President, Corporate Communications
Flexion Therapeutics Inc
-(FLXN)
XNAS:FLXN
Flexion Therapeutics plunges after reporting preliminary Q4 financial results
Flexion Therapeutics (Nasdaq: FLXN) reported its preliminary fourth quarter earnings results after the bell today. The biopharmaceutical company's Q4 revenue is expected to be